Third Annual Global Summit: Global Kidney Innovations – Expanding Patient Choices & Outcomes
A collaborative partnership event presented by the American Association of Kidney Patients and The George Washington University School of Medicine & Health Sciences
Emerging Research in Kidney Disease with Global Implications: Kidney Disease Management & Pre-emptive Treatments for Diabetic Kidney Disease
Moderator:
Paul T. Conway, AAKP Chair of Policy & Global Affairs; Global Summit Co-Chair, Board of Directors, Kidney Health Initiative (KHI); former dialysis patient, current transplant recipient
Speakers:
– Ikenna Ogbaa, MD, Executive Medical Director, Cardio and Renal US Medical Affairs, Bayer Pharmaceuticals (USA)
– Daniel Wilson, MD, Senior Medical Director, Bayer Pharmaceuticals (USA)
– Susan E. Quaggin, MD, FASN, American Society of Nephrology President; Chair of ASN Diabetic Kidney Disease Collaborative; Director, Feinberg Cardiovascular & Renal Research Institute; Chief of Nephrology & Hypertension, Department of Medicine, Northwestern University (USA)
– Katherine R. Tuttle, MD, FASN, FACP, FNKF, Executive Director for Research, Providence Health Care; Professor of Medicine, University of Washington; Co-PI, Institute of Translational Health Sciences (USA)
source